Sodyum tiyopental - Vikipedi

Sodyum tiyopental, hızlı başlangıçlı kısa etkili bir barbitürat genel anesteziktir. Pentobarbitalin tiyobarbiturat analoğudur ve tiyobarbitalin bir analoğudur. Sodyum tiyopental, Dünya Sağlık Örgütü'nün Temel İlaçlar Listesi'nde^[1] temel bir ilaçtı, ancak yerini propofol aldı.^[2]^[3]^[4] Buna rağmen, tiyopental, bu ajanların yerel mevcudiyetine ve maliyetine bağlı olarak propofol için kabul edilebilir bir alternatif olarak listelenmiştir.^[4] Tiyopentalin kötüye kullanımı bağımlılık riski taşımasına rağmen, eğlence amaçlı kullanımı nadirdir.^[5]

Kaynakça

^ WHO Model List of Essential Medicines 16th list, March 2009. Geneva, Switzerland: World Health Organization. 2009.
^ The selection and use of essential medicines : report of the WHO Expert Committee, March 2011 (including the 17th WHO model list of essential medicines and the 3rd WHO model list of essential medicines for children). Cenevre: World Health Organization. 2012. ISBN 9789241209656. ISSN 0512-3054. WHO technical report series ; 965.
^ World Health Organization model list of essential medicines: 21st list 2019. Cenevre: World Health Organization. 2019. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
^ ^a ^b World Health Organization model list of essential medicines: 22nd list (2021). Cenevre: World Health Organization. 2021. WHO/MHP/HPS/EML/2021.02.
^ Substance abuse: inpatient and outpatient management for every clinician. Kaye, Alan David,, Vadivelu, Nalini,, Urman, Richard D. New York. December 2014. ISBN 978-1493919512. OCLC 897466425.

[1] WHO Model List of Essential Medicines 16th list, March 2009. Geneva, Switzerland: World Health Organization. 2009.

[2] The selection and use of essential medicines : report of the WHO Expert Committee, March 2011 (including the 17th WHO model list of essential medicines and the 3rd WHO model list of essential medicines for children). Cenevre: World Health Organization. 2012. ISBN 9789241209656. ISSN 0512-3054. WHO technical report series ; 965.

[WHO21st-3] World Health Organization model list of essential medicines: 21st list 2019. Cenevre: World Health Organization. 2019. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

[WHO22nd-4] World Health Organization model list of essential medicines: 22nd list (2021). Cenevre: World Health Organization. 2021. WHO/MHP/HPS/EML/2021.02.

[5] Substance abuse: inpatient and outpatient management for every clinician. Kaye, Alan David,, Vadivelu, Nalini,, Urman, Richard D. New York. December 2014. ISBN 978-1493919512. OCLC 897466425.

[1]

[2]

[3]

[4]

[5]